Results 181 to 190 of about 71,938 (313)

Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy. [PDF]

open access: yesSci Adv
Jaber A   +21 more
europepmc   +1 more source

Psychometric evaluation of the PROMIS parent proxy mobility item bank for use in Duchenne muscular dystrophy

open access: hybrid
Linda Lowes   +6 more
openalex   +1 more source

Observational study of changes to glucocorticosteroid prescribing patterns in duchenne muscular dystrophy in the UK over the last decade

open access: green
Gregory Landon   +6 more
openalex   +2 more sources

Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors

open access: gold, 2016
Yoshitsugu Aoki   +3 more
openalex   +2 more sources

Exploring the Role of Telemedicine in Duchenne Muscular Dystrophy: Benefits and Challenges. [PDF]

open access: yesJMIR Form Res
Wasilewska E   +10 more
europepmc   +1 more source

Cardioprotection in Duchenne muscular dystrophy

open access: yesEuropean Heart Journal, 2021
Anjali Tiku Owens, Mariell Jessup
openaire   +2 more sources

Left bundle branch block in Duchenne muscular dystrophy: Prevalence, genetic relationship and prognosis

open access: gold, 2018
Abdallah Fayssoil   +17 more
openalex   +2 more sources

Multiomics Analysis of the mdx/mTR Mouse Model of Duchenne Muscular Dystrophy [PDF]

open access: green, 2019
Douglas W. Van Pelt   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy